CHANGE IN RATINGS

ATI Technologies

downgraded at CSFB: CSFB said it is downgrading ATYT to Neutral from Outperform based on soft demand trends in PC market, excess chipset inventory and high near-term expectations. Lowered target price to $15 from $19.

Building Materials Holding

downgraded by SunTrust Robinson Humphrey: SunTrust said it is downgrading BMHC to Neutral as home buying markets get grimmer in the Southwest.

Coca Cola Enterprises

upgraded at Morgan Stanley: Morgan Stanley said it is increasing its rating on CCE to Overweight from Equalweight based on an improved risk/reward scenario. Target to $24.50 from $23.

Coventry Health

upgraded at Prudential: CVH was upgraded from Neutral to Overweight, Prudential said. $60 price target. Estimates also raised, as recent pricing surveys show improving fundamentals.

Global Crossing

coverage initiated at Goldman: Goldman said it is initiating coverage on GLBC with an Outperform rating.

JP Morgan

downgraded at Prudential: JPM was downgraded to Neutral from Overweight, Prudential said. $45 price target. Estimates also lowered, to reflect recent capital market weakness. Rate environment also continues to deteriorate.

Pepsi

upgraded at Stifel Nicolaus: Stifle Nicolaus said it is upgrading PEP to Buy from Hold based on expected multiple expansion and double-digit earnings growth. Raised 2006 estimates to $2.98 from $2.96 and introduced price target of $68.

RF Micro Devices

upgraded at CSFB: CSFB said it is upgrading RFMD to Neutral from Underperform. Believes current dynamics reflect moderation from aggressive forecasts to start the year. Lowered target price to $7.20 from $8.00.

Time Warner Telecom

upgraded at Bear: TWTC was upgraded from Underperform to Peer Perform, Bear Stearns said. Met with management in Denver this week, and the company is seeing pricing stability across the board.

Varian Medical

upgraded at Oppenheimer: VAR was upgraded from Neutral to Buy, Oppenheimer said. $55 price target. Stock has dropped 25% in the past four months, though the oncology business continues to enjoy strong momentum.

STOCK COMMENTS / EPS CHANGES

Affiliated Computer Sciences

estimates lowered at Jefferies: Jefferies said it is lowering its 2006 estimates on ACS by 3 cents to $3.03 due to low visibility, SEC inquiry into option program, and loss of momentum in government services unit. Maintain Outperform rating.

Apollo Group

estimates raised at UBS: UBS said it is raising its EPS estimates on APOL by 10 cents to $2.56. Cites enrollments are solid but investors seem skeptical. Maintained Neutral rating.

Apollo Group

outlook raised at Morgan Stanley: Morgan Stanley said it is increasing its estimates on APOL for the full year to $2.62 a share from $2.57 a share. Target raised to $63 a share from $62 a share. Maintained Overweight rating.

Actuant

target price cut at UBS: UBS said it is lowering its target price on ATU to $53 from $65 following negative guidance by management. Maintained Neutral rating.

Actuant

outlook lowered at Goldman: Goldman said it is lowering its estimates on ATU for the full year to $2.89 a share from $2.95 a share. Stock weakness is overdone.

Belo

outlook lowered at Goldman: Goldman said it is lowering its estimates on BLC for the full year to $1.13 a share from $1.19 a share. Maintained Inline rating.

Darden Restaurants

estimates raised at UBS: UBS said it is raising its 2007 EPS estimates on DRI by a penny to $2.38 following strong fundamentals in 4Q results. Maintained Buy rating.

Darden Restaurants

outlook raised at Goldman: Goldman said it is increasing its estimates on DRI for the full year to $2.35 a share from $2.29 a share. Maintained Underperform rating.

Johnson Controls

numbers boosted at Prudential: JCI target raised to $93, Prudential said. Estimates also boosted, because of merger synergies. Battery margins are increasing from process improvements. Overweight rating.

Kroger

estimates boosted at Morgan Stanley: Morgan Stanley said it is increasing its estimates on KR for the year ending Jan. 2007 to $1.31 a share from $1.29 a share. Company beat estimates for its fiscal first quarter.

Praxair

estimates raised at Jefferies:Jefferies said it is upping its 2006 estimates on PX by 2 cents to $2.82 due to improving business trends and sustained pricing power. Reiterated Hold rating. Price target at $59.

Scientific Games

outlook cut at Morgan Stanley: Morgan Stanley said it is lowering its estimates on SGMS for the full year to $1.25 a share from $1.34 a share. Target is $37 a share.

Sonic

estimates raised at Jefferies: Jefferies said it is raising its 2006 estimates on SONC by a penny to $0.87 due to a more favorable tax rate. Maintain Peer Perform rating.